Dr. Bertrand Routy MD/PhD graduated from McGill University Internal Medicine program in 2012 and completed a hematology fellowship at the Princess Margaret Hospital, University of Toronto in 2014. At Princess Margaret, he oriented his career towards immunotherapy and joined the laboratory of Dr. Armand Keating. Subsequently, he obtained a PhD in immuno-onoclogy at Gustave Roussy
Biography
Dr. Bertrand Routy MD/PhD graduated from McGill University Internal Medicine program in 2012 and completed a hematology fellowship at the Princess Margaret Hospital, University of Toronto in 2014. At Princess Margaret, he oriented his career towards immunotherapy and joined the laboratory of Dr. Armand Keating. Subsequently, he obtained a PhD in immuno-onoclogy at Gustave Roussy Cancer Campus in Paris under the supervision of Pr. Laurence Zitvogel. During his training, he showed the deleterious impact of antibiotics on patients receiving immune checkpoint inhibitors (ICI). Furthermore, he demonstrated that the gut microbiota composition has a major impact on ICI efficacy in various cancers.
In 2018, Dr. Routy became assistant professor of hemato-oncology and the scientific director of the Immunotherapy and Oncomicrobiome laboratory at the University of Montreal Research Center.
All session by Bertrand Routy
14.30
